A role for fulvestrant monotherapy in the first‐line treatment of ER+ metastatic breast cancer?-Reference-Cited by-同舟云学术

A role for fulvestrant monotherapy in the first‐line treatment of ER+ metastatic breast cancer?

Published:2019-09-20 Issue:2 Volume:26 Page:109-111
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Mahtani Reshma L.¹

Affiliation:

1. Division of hematology/Oncology, Sylvester Comprehensive Cancer Center University of Miami Health System Deerfield Beach Florida

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.13495

Reference18 articles.

1. Fate of Steroid Estrogens in Target Tissues

2. National Comprehensive Cancer Network.Breast Cancer Guidelines (Version 3.2018).https://www.nccn.org/professionals/physician_gls/pdf/breast_blocks.pdf. Accessed February 8 2019.

3. Fulvestrant, Formerly ICI 182,780, Is as Effective as Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing After Prior Endocrine Treatment

4. Double-Blind, Randomized Trial Comparing the Efficacy and Tolerability of Fulvestrant Versus Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing on Prior Endocrine Therapy: Results of a North American Trial

5. FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer Therapeutics and Biomarkers: Past, Present, and Future Approaches;Breast Cancer: Basic and Clinical Research;2021-01

2. Pharmacological Modulation of Steroid Activity in Hormone-Dependent Breast and Prostate Cancers: Effect of Some Plant Extract Derivatives;International Journal of Molecular Sciences;2020-05-23